1887

Abstract

Herpes simplex virus (HSV) ocular virulence has been associated with strain sensitivity to mouse interferon (IFN)-/. To identifiy the region of the virus genome associated with heightened resistance to this cytokine, intertypic recombinants were constructed using the intact genome of avirulent, IFN-sensitive HSV type 1 (strain 35) and I-digested DNA from virulent, IFN-resistant HSV type 2 (strain 186). An intertypic recombinant, designated HSV-R4, was isolated which grew to titres 10- to 100-fold higher than HSV-1(35) in mouse ocular tissue , and induced stromal keratitis. The recombinant which was several orders of magnitude more resistant to mouse IFN-/ than HSV-1(35) had a genome composed of HSV-1(35) DNA except for a 12 kb fragment (0.15 to 0.23 map units) derived from HSV-2(186). To define the IFN resistance locus further, three overlapping subclones of this 12 kb fragment were constructed from the HSV-2(186) genome and subjected to marker rescue experiments. The cloned HI D fragment was the only subclone that promoted HSV-1(35) ocular growth . An intertypic recombinant, designated HSV-R(BD), was isolated from the 35 × 186 HI D transfection progeny pool. This recombinant, in contrast to HSV-1(35), was several orders of magnitude more resistant to mouse IFN-/ inhibition , grew 10- to 100-fold better in mouse ocular tissue , and caused severe necrotizing stromal keratitis in BALB/c mice. Analysis of the recombinant genome indicated that the HSV-2 genetic information responsible for IFN resistance of HSV-R(BD) was located within the HI D fragment, most likely mapping to that region containing three partial open reading frames designated UL14, UL15 and UL16. The products encoded by this region remain to be identified.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-11-2325
1993-11-01
2022-08-10
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/11/JV0740112325.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-11-2325&mimeType=html&fmt=ahah

References

  1. Black T. L., Safer B., Hovanessian A., Katze M. G. 1989; The cellular 68, 000-M r protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. Journal of Virology 63:2244–2251
    [Google Scholar]
  2. Cayley P. J., Davies J. A., McCullaugh K. G., Kerr I. M. 1984; Activation of the ppp(A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA dependent RNase. European Journal of Biochemistry 143:165–174
    [Google Scholar]
  3. Day S. P., Lausch R. N., Oakes J. E. 1988; Evidence that the gene for herpes simplex virus type 1 DNA polymerase accounts for the capacity of an intertypic recombinant to spread from eye to central nervous system. Virology 163:166–173
    [Google Scholar]
  4. De Maeyer E., De Maeyer-Guignard J. 1988 Interferons and Other Regulatory Cytokines pp 114–133 New York: John Wiley;
    [Google Scholar]
  5. De Stasio P. R., Taylor M. W. 1989; Trans-activation of herpes simplex virus type 1 immediate early genes is specifically inhibited by human recombinant interferons. Biochemical and Biophysical Research Communications 159:439–444
    [Google Scholar]
  6. Domke-Opitz I., Straub P., Kirchner H. 1986; Effect of interferon on replication of herpes simplex virus types 1 and 2 in human macrophages. Journal of Virology 60:37–42
    [Google Scholar]
  7. Feduchi E., Alonso M. A., Carrasco L. 1989; Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. Journal of Virology 63:1354–1359
    [Google Scholar]
  8. Gaines K. L., Kayes S. G., Wilson G. L. 1987; Factors affecting the infection of the D variant of encephalomyocarditis virus in the B cells of C57BL/6J mice. Diabetologia 30:419–425
    [Google Scholar]
  9. Graham F. L., van der Eb A. J. 1973; A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–467
    [Google Scholar]
  10. Gresser I., Tovey M. G., Maury C., Bandu M. T. 1976; Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. Journal of Experimental Medicine 144:1316–1329
    [Google Scholar]
  11. Gunnery S., Rice A. P., Robertson H. D., Mathews M. B. 1990; Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded RNA-activated protein kinase. Proceedings of the National Academy of Sciences, U,. S,. A 87:8687–8691
    [Google Scholar]
  12. Habu S., Akamatsu K., Tamaoki N., Okumura K. 1984; In vivo significance of NK cells on resistance against virus (HSV-1) infections in mice. Journal of Immunology 133:2743–2747
    [Google Scholar]
  13. Hanahan D. 1983; Studies on transformation of Escherichia coli with plasmids. Journal of Molecular Biology 166:557–580
    [Google Scholar]
  14. Holmes D. S., Quigley M. 1981; A rapid boiling method for the preparation of bacterial plasmids. Analytical Biochemistry 114:193–197
    [Google Scholar]
  15. Howley P. M., Israel M. A., Law M. F., Martin M. A. 1979; A rapid method for detecting and mapping homology between heterologous DNA. Journal of Biological Chemistry 254:4876–4883
    [Google Scholar]
  16. Imani F., Jacobs B. 1988; Inhibitory activity of the interferon-induced protein kinase is associated with the reovirus serotype 1σ3 protein. Proceedings of the National Academy of Sciences, U,. S,. A 85:7887–7891
    [Google Scholar]
  17. Katze M. G., Detjen B. M., Safer B., Krug R. M. 1986; Translational control by influenza virus: suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza virus mRNAs. Molecular and Cellular Biology 6:1741–1750
    [Google Scholar]
  18. Kitajewski J. R., Schneider J., Safer B., Munemitsu S. M., Samuel C. E., Thimmappaya B., Shenk T. 1986; Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2α kinase. Cell 45:195–200
    [Google Scholar]
  19. Kristie T. M., Lebowitz J. H., Sharp P. A. 1989; The octamer-binding proteins form multi-protein-DNA complexes with the HSV αTIF regulatory protein. EMBO Journal 8:4229–1238
    [Google Scholar]
  20. LaMarco K. L., McKnight L. 1989; Purification of a set of cellular polypeptides that bind to the purine-rich cis-regulatory element of herpes simplex virus immediate early genes. Genes and Development 3:1372–1383
    [Google Scholar]
  21. Lausch R. N., Yeung K. C., Miller J. Z., Oakes J. E. 1990; Nucleotide sequences responsible for the inability of a herpes simplex virus type 2 strain to grow in human lymphocytes are identical to those responsible for its inability to grow in mouse tissues following ocular infection. Virology 176:319–328
    [Google Scholar]
  22. Lausch R. N., Su Y. -H., Ritchie M., Oakes J. E. 1991; Evidence endogenous interferon production contributed to the lack of ocular virulence of an HSV intertypic recombinant. Current Eye Research 10:39–45
    [Google Scholar]
  23. Lee T. G., Tomita J., Hovanessian A. G., Katze M. G. 1990; Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of M r 68, 000 from influenza virus-infected cells. Proceedings of the National Academy of Sciences, U,. S,. A. 87:6208–6212
    [Google Scholar]
  24. McGeoch D. J., Dalrymple M. A., Davison A. J., Dolan A., Frame M. C., McNab D., Perry L. J., Scott J. E., Taylor P. 1988; The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. Journal of General Virology 69:1531–1574
    [Google Scholar]
  25. Mellits K. H., Kostura M., Mathews M. B. 1990; Interaction of adenovirus VA RNA I with the protein kinase DAI: nonequivalence of binding and function. Cell 61:843–852
    [Google Scholar]
  26. Metcalf J. F., Koga J., Chatterjee S., Whitley R. J. 1987; Passive immunization with monoclonal antibodies against herpes simplex virus glycoproteins protects mice against herpetic ocular disease. Current Eye Research 6:173–177
    [Google Scholar]
  27. Mittnacht S., Straub P., Kirchner H., Jacobsen H. 1988; Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. Virology 164:201–210
    [Google Scholar]
  28. Muñoz A., Carrasco L. 1984; Formation of non-infective herpesvirus particles in cultured cells treated with human interferon. Journal of General Virology 65:1069–1078
    [Google Scholar]
  29. Oberman F., Panet A. 1988; Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells. Journal of General Virology 69:1167–1177
    [Google Scholar]
  30. Paez E., Esteban M. 1984; Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system. Virology 134:12–28
    [Google Scholar]
  31. Pearson W. R., Lipman D. J. 1988; Improved tools for biological sequence comparison. Proceedings of the National Academy of Sciences, U,. S,. A 85:2444–2448
    [Google Scholar]
  32. Preston C. M., Frame M. C., Campbell M. E. M. 1988; A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence. Cell 52:425–134
    [Google Scholar]
  33. Ritchie M. H., Oakes J. E., Lausch R. M. 1993; Passive transfer of anti-HSV-2 monoclonal and polyclonal antibodies protect against HSV-1 but not HSV-2 induced stromal keratitis. Investigative Ophthalmology and Visual Science (in press)
    [Google Scholar]
  34. Roy S., Katze M. G., Parkin N., Edery I., Hovanessian A., Sonenberg N. 1990; Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247:1216–1219
    [Google Scholar]
  35. Southern E. M. 1975; Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 98:503–517
    [Google Scholar]
  36. Straub P., Domke I., Kirchner H., Jacobsen H., Panet A. 1986; Synthesis of herpes simplex virus proteins and nucleic acids in interferon-treated macrophages. Virology 150:411–118
    [Google Scholar]
  37. Su Y. -H., Oakes J. E., Lausch R. N. 1990; Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beat interferon. Journal of Virology 64:2187–2192
    [Google Scholar]
  38. Walboomers J. M. M., ter Schegget J. 1976; A new method for the isolation of herpes simplex virus type 2 DNA. Virology 74:256–258
    [Google Scholar]
  39. Wander A. H., Centifanto Y. M., Kaufman H. E. 1980; Strain specificity of clinical isolates of herpes simplex virus. Archives of Ophthalmology 98:1458–1467
    [Google Scholar]
  40. Whitaker-Dowling P., Youngner J. 1984; Characterization of a specific kinase inhibitory factor produced by vaccinia virus which inhibits the interferon-induced protein kinase. Virology 137:171–181
    [Google Scholar]
  41. Zawatzky R., Hilfenhaus J., Marcucci F., Kirchner H. 1981; Experimental infection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunity and of interferon induction. Journal of General Virology 53:31–38
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-11-2325
Loading
/content/journal/jgv/10.1099/0022-1317-74-11-2325
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error